Orange Book product · Generic (ANDA)
PHENYLEPHRINE HYDROCHLORIDE
PHENYLEPHRINE HYDROCHLORIDE
At a glance
May 23, 2024
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 23, 2024
2 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
PHENYLEPHRINE HYDROCHLORIDE
Strength
2.5%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT
Application
ANDA 215183
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PHENYLEPHRINE HYDROCHLORIDE
- 2025PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEBrand (NDA)
NDA 216830 · DR REDDYS LABS SA
- 2023IMMPHENTIVBrand (NDA)
NDA 203826 · HIKMA
- 2019BIORPHENBrand (NDA)
NDA 212909 · DR REDDYS LABS SA
- 2015PHENYLEPHRINE HYDROCHLORIDEBrand (NDA)
NDA 207926 · ALCON
- 2014VAZCULEPBrand (NDA)
NDA 204300 · EXELA PHARMA
- 2013PHENYLEPHRINE HYDROCHLORIDEBrand (NDA)
NDA 203510 · PARAGON BIOTECK
- 2026PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217032 · BAXTER HLTHCARE CORP
- 2025PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215617 · SOMERSET THERAPS LLC
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218129 · GLAND
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218110 · ASPIRO
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218412 · HAINAN POLY
- 2023PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217521 · BE PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
